Fredun Pharmaceuticals Complete Financial Statements
In FY2026, Fredun Pharmaceuticals (FREDUN) reported revenue ₹210 Cr, net profit ₹11 Cr and EPS ₹19.70, with a net profit margin of 5.2% and ROE of 4.0%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Fredun Pharmaceuticals stock price NSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
FREDUN Revenue, Net Profit & EBITDA — Year-on-Year Growth
FREDUN YoY (Mar 2025 vs Mar 2026) — revenue +27.3%, net profit +83.3%, EBITDA +73.3%, expenses +22.7%. Analyse FREDUN promoter holding to track promoter, FII and institutional holdings.
FREDUN Income Statement — Revenue, EBITDA & Net Profit
Fredun Pharmaceuticals revenue ₹210 Cr, EBITDA ₹26 Cr, net profit ₹11 Cr, EPS ₹19.70 (2026) — net profit margin 5.2%. Examine Fredun Pharmaceuticals quarterly financials for recent quarterly revenue, profit and EPS trends.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 210 | 144 | 165 | 119 | 160 | 0 | 0 | 286 |
| Expenses | 184 | 123 | 150 | 103 | 135 | 0 | 0 | 251 |
| EBITDA | 26 | 21 | 15 | 17 | 25 | 0 | 0 | 35 |
| Operating Profit Margin % | 12.00% | 14.00% | 9.00% | 14.00% | 16.00% | 0.00% | 0.00% | 12.00% |
| Depreciation | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 3 |
| Interest | 15 | 8 | 8 | 7 | 11 | 0 | 0 | 14 |
| Profit Before Tax | 11 | 13 | 7 | 9 | 14 | 0 | 0 | 20 |
| Tax | 1 | 3 | 1 | 2 | 4 | 0 | 0 | 7 |
| Net Profit | 11 | 9 | 6 | 7 | 11 | 0 | 0 | 14 |
| Earnings Per Share (₹) | 19.70 | 19.98 | 12.71 | 14.33 | 22.19 | 0.00 | 0.00 | 29.09 |
FREDUN Balance Sheet — Assets, Liabilities & Shareholders' Equity
FREDUN total assets ₹642 Cr, total equity ₹278 Cr, total liabilities ₹ Cr (2026) — ROE 4.0%.
| Particulars | 2026 | 2025 |
|---|---|---|
| ASSETS | ||
| Total Assets | 642 | 487 |
| Current Assets | 498 | 427 |
| Fixed Assets | 118 | 53 |
| Capital Work in Progress | 0 | 0 |
| Investments | 2 | 2 |
| Other Assets | 522 | 433 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 67 | 18 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 278 | 141 |
| Share Capital | 6 | 5 |
| Reserves & Surplus | 259 | 137 |
FREDUN Cash Flow Statement — Operating, Investing & Financing
Fredun Pharmaceuticals operating cash flow ₹12 Cr, investing ₹-74 Cr, financing ₹121 Cr, net cash flow ₹60 Cr (2026).
| Particulars | March 2026 | March 2025 |
|---|---|---|
| Operating Activities | 12 | -17 |
| Investing Activities | -74 | -6 |
| Financing Activities | 121 | 27 |
| Net Cash Flow | 60 | 4 |